When Salmonella enters a body, in some cases it can infect cells in the intestines. Sometimes these bacteria cause serious ...

A RAND Corporation study analyzed colorectal cancer trends in the U.S. from 1978 to 2017, revealing declining rates in older adults due to widespread screening but rising early-onset cases linked to ...

Discover a groundbreaking cancer treatment from KAIST that transforms colon cancer cells back to healthy ones offering hope for safer side-effect-free therapies ...

Despite advancements in cancer treatment technologies, most therapies share a common goal: eliminating cancer cells. However, ...

Stenoparib is under clinical development by Allarity Therapeutics and currently in Phase I for Colon Cancer. According to GlobalData, Phase I drugs for Colon Cancer have a 56% phase transition success ...

Using a computational “digital twin” model, researchers mapped the gene networks controlling cell differentiation. They ...

Scientists at KAIST have developed a groundbreaking method to convert colon cancer cells into healthy ones using a ...

KAIST researchers have developed new technology that can transform colon cancer cells into normal-like cells. Led by ...

This is a significant departure from traditional cancer treatments that rely on killing cancer cells, often leading to severe ...

Despite the development of numerous cancer treatment technologies, the common goal of current cancer therapies is to ...